9th International Conference on
Cardiology & Cardiovascular Diseases

Jonathan Alvin Wiryaputra

National Cardiovascular Center Harapan Kita Hospital, Indonesia

Abstract Title: Future Directions in Heart Transplantation: Innovation, Integration, and Possibility

Biography:

Research Interests:

Heart transplantation remains the most effective treatment for end-stage heart failure, yet its broader application is limited by donor organ scarcity, immune rejection, and long-term graft dysfunction. As global demand continues to rise, transformative approaches are emerging to redefine the landscape of cardiac replacement therapy. Recent progress in xenotransplantation—particularly the use of genetically modified porcine hearts—has shown early clinical feasibility in overcoming acute rejection, offering a potential solution to donor shortages. Simultaneously, breakthroughs in regenerative medicine, including 3D bioprinting and tissue engineering, are accelerating the development of patient-specific, immunocompatible cardiac grafts. Advances in immunomodulatory strategies—such as tolerance-inducing therapies and gene-editing techniques—are being explored to minimize dependence on lifelong immunosuppression. Additionally, artificial intelligence and machine learning are enhancing donor-recipient matching and early detection of graft failure, improving clinical precision and long-term outcomes. Despite these promising developments, substantial ethical, regulatory, and logistical barriers remain. Rigorous translational research and global collaboration will be essential to bring these innovations from laboratory to bedside.